BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36603559)

  • 1. Identification of Hub Genes Correlated with the Initiation and Development in Chronic Kidney Disease via Bioinformatics Analysis.
    Zhu K; Li X; Gao L; Ji M; Huang X; Zhao Y; Diao W; Fan Y; Chen X; Luo P; Shen L; Li L
    Kidney Blood Press Res; 2023; 48(1):79-91. PubMed ID: 36603559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene network in pulmonary tuberculosis based on bioinformatic analysis.
    Li L; Lv J; He Y; Wang Z
    BMC Infect Dis; 2020 Aug; 20(1):612. PubMed ID: 32811479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel targets in renal fibrosis based on bioinformatic analysis.
    Yuan Y; Xiong X; Li L; Luo P
    Front Genet; 2022; 13():1046854. PubMed ID: 36523757
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis.
    Liang Z; Hu X; Lin R; Tang Z; Ye Z; Mao R; Chen W; Zhou Y
    Front Immunol; 2023; 14():1078310. PubMed ID: 36860851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of Chronic Kidney Disease.
    Zhou LT; Qiu S; Lv LL; Li ZL; Liu H; Tang RN; Ma KL; Liu BC
    Kidney Blood Press Res; 2018; 43(2):568-581. PubMed ID: 29642064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
    Zhang H; Huo J; Jiang W; Shan Q
    Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
    Chen C; Wu Y; Lu HL; Liu K; Qin X
    PeerJ; 2022; 10():e13138. PubMed ID: 35313524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis.
    Deng YX; Liu K; Qiu QX; Tang ZY; Que RM; Li DK; Gu XR; Zhou GL; Wu YF; Zhou LY; Yin WJ; Zuo XC
    Front Immunol; 2023; 14():1126348. PubMed ID: 37063876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
    Chen B; Sun D; Qin X; Gao XH
    Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the pivotal role of SPP1 in kidney stone disease based on multiple bioinformatics analysis.
    Hong SY; Xia QD; Xu JZ; Liu CQ; Sun JX; Xun Y; Wang SG
    BMC Med Genomics; 2022 Jan; 15(1):7. PubMed ID: 35016690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets.
    Jin J; Liu Y; Tang Q; Yan X; Jiang M; Zhao X; Chen J; Jin C; Ou Q; Zhao J
    Front Immunol; 2023; 14():1125183. PubMed ID: 37063926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Differentially Expressed Genes and Signaling Pathways in Acute Myocardial Infarction Based on Integrated Bioinformatics Analysis.
    Chen DQ; Kong XS; Shen XB; Huang MZ; Zheng JP; Sun J; Xu SH
    Cardiovasc Ther; 2019; 2019():8490707. PubMed ID: 31772617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components.
    Huang T; Ding J; Lin L; Han L; Yu L; Li M
    Front Biosci (Landmark Ed); 2023 Nov; 28(11):293. PubMed ID: 38062833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.